Condition
Metabolic Glucose Disorders
Total Trials
4
Recruiting
0
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Active Not Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05874635Not ApplicableActive Not Recruiting
Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)
NCT05121844Not ApplicableActive Not Recruiting
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
NCT03857802Not ApplicableCompleted
Efficiency of a Nursing Intervention in Sleep Hygiene
NCT04268862Unknown
Metabolic Defects in Prediabetic Kuwaiti Arabs and Indians
Showing all 4 trials